Jacobs Levy Equity Management
IOVA icon

Jacobs Levy Equity Management’s Iovance Biotherapeutics IOVA Stock Holding History

Jacobs Levy Equity Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,788
Closed -$34.9K – 1014
2025
Q4 		$34.9K Buy
+12,788
New +$29.6K ﹤0.01% 916
2025
Q2 		– Sell
-1,258,561
Closed -$4.19M – 1102
2025
Q1 		$4.19M Buy
+1,258,561
New +$6.49M 0.02% 502
2023
Q3 		– Sell
-515,035
Closed -$3.63M – 1010
2023
Q2 		$3.63M Sell
515,035
-1,045,893
-67% -$7.49M 0.02% 464
2023
Q1 		$9.54M Buy
1,560,928
+1,099,468
+238% +$7.59M 0.06% 293
2022
Q4 		$2.95M Buy
461,460
+276,063
+149% +$2.16M 0.02% 480
2022
Q3 		$1.78M Buy
185,397
+14,743
+9% +$170K 0.01% 583
2022
Q2 		$1.88M Buy
+170,654
New +$2.24M 0.01% 613

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return